Cargando…

Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers

The immunosuppressive activity of mesenchymal stromal cells (MSCs) in graft versus host disease (GvHD) is well-documented, but their therapeutic benefit is rather unpredictable. Prospective randomized clinical trials remain the only means to address MSC clinical efficacy. However, the imperfect unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheung, Tik Shing, Bertolino, Giuliana Minani, Giacomini, Chiara, Bornhäuser, Martin, Dazzi, Francesco, Galleu, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330053/ https://www.ncbi.nlm.nih.gov/pubmed/32670295 http://dx.doi.org/10.3389/fimmu.2020.01338

Ejemplares similares

Multiparametric Analysis of Circulating Exosomes and Other Small Extracellular Vesicles by Advanced Imaging Flow Cytometry
por: Mastoridis, Sotiris, et al.
Publicado: (2018)

Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
por: Kelly, Kilian, et al.
Publicado: (2021)

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation
por: Trento, Cristina, et al.
Publicado: (2018)

Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival
por: Galleu, Antonio, et al.
Publicado: (2019)

Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
por: Krüger, Thomas, et al.
Publicado: (2022)

Recent Advances in Extracellular Vesicle-Based Therapies Using Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells
por: Bertolino, Giuliana Minani, et al.
Publicado: (2022)

Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
por: Stenger, Elizabeth, et al.
Publicado: (2022)

The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair
por: Giacomini, Chiara, et al.
Publicado: (2023)

Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017)

Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
por: Ringdén, Olle, et al.
Publicado: (2022)

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020)

Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
por: Ringdén, Olle, et al.
Publicado: (2020)

Dichotomic Potency of IFNγ Licensed Allogeneic Mesenchymal Stromal Cells in Animal Models of Acute Radiation Syndrome and Graft Versus Host Disease
por: Chinnadurai, Raghavan, et al.
Publicado: (2021)

Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector
por: Sweeney, Nathan Paul, et al.
Publicado: (2016)

Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update
por: Müller, Luise, et al.
Publicado: (2021)

Improved efficacy of mesenchymal stromal cells stably expressing CXCR4 and IL-10 in a xenogeneic graft versus host disease mouse model
por: Hervás-Salcedo, Rosario, et al.
Publicado: (2023)

Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b(+) cells that expedite hematopoietic recovery
por: Trento, Cristina, et al.
Publicado: (2017)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease via engagement of PD-1 ligands
por: Hackel, Alexander, et al.
Publicado: (2023)

NOTCH and Graft-Versus-Host Disease
por: Di Ianni, Mauro, et al.
Publicado: (2018)

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease
por: Stikvoort, Arwen, et al.
Publicado: (2017)

Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model
por: Grégoire, Céline, et al.
Publicado: (2019)

Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
por: Baygan, Arjang, et al.
Publicado: (2017)

Adult human mesenchymal stromal cells and the treatment of graft versus host disease
por: Herrmann, Richard P, et al.
Publicado: (2014)

Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
por: Dunavin, Neil, et al.
Publicado: (2017)

Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
por: Godoy, Juliana A. P., et al.
Publicado: (2019)

Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
por: Kadri, Nadir, et al.
Publicado: (2023)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
por: Dekker, Linde, et al.
Publicado: (2022)

T-Cell Metabolism in Graft Versus Host Disease
por: Karl, Franziska, et al.
Publicado: (2021)

Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products
por: Murata, Makoto, et al.
Publicado: (2021)

Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease
por: Jaing, Tang-Her, et al.
Publicado: (2023)

Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate
por: Han, Jingjing, et al.
Publicado: (2017)

Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
por: Zhang, Lingling, et al.
Publicado: (2018)

Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease
por: Santos e Sousa, Pedro, et al.
Publicado: (2018)

Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease
por: Betts, Brian C., et al.
Publicado: (2019)

Role of endothelial cells in graft-versus-host disease
por: Neidemire-Colley, Lotus, et al.
Publicado: (2022)

Recent advances in ocular graft-versus-host disease
por: Cheng, Xianjing, et al.
Publicado: (2023)

Editorial: Regulatory T cells in graft versus host disease
por: Rodríguez-Gil, Alfonso, et al.
Publicado: (2023)

Alloreactivity of Virus-Specific T Cells: Possible Implication of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effects
por: Fuji, Shigeo, et al.
Publicado: (2013)

Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
por: Morata-Tarifa, Cynthia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uejsqdkq9sjj6puvhvnb8bq2c2